Latest filing published 15 Sept 2026 for Neurocrine Biosciences INC.
This profile gathers the share dealings of Jude Onyia in Neurocrine Biosciences Inc. We count 26 filings; the first trade dates from 29 November 2022 and the latest from 11 September 2026.
Sales make up the whole of the open-market record (11 sales, €2.1M). Other entries cover 2 share grants and 9 option exercises.
The record was last updated on 15 September 2026 with a share grant in Neurocrine Biosciences Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 26 declarations